Also trades as: SRTAW (NASDAQ) · $vol 0M
SRTA NASDAQ
Strata Critical Medical, Inc.
1W: +6.0%
1M: +16.0%
3M: +28.9%
YTD: +17.6%
1Y: +66.2%
3Y: +96.0%
5Y: -18.0%
$6.13
+0.33 (+5.69%)
Weekly Expected Move ±8.7%
$4
$5
$5
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$197M
-20.7% ▼
5Y CAGR: +53.1%
Gross Profit
$41M
-30.2% ▼
5Y CAGR: +77.6%
Operating Income
-$22M
+34.1% ▲
Net Income
$41M
+251.4% ▲
EPS (Diluted)
$0.50
+242.9% ▲
EBITDA
-$12M
+57.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $51M | $146M | $225M | $249M | $197M |
| YoY Growth | +115.6% | +189.2% | +54.1% | +10.4% | -20.7% |
| Cost of Revenue | $40M | $124M | $183M | $190M | $156M |
| Gross Profit | $11M | $22M | $42M | $59M | $41M |
| Gross Margin | 20.8% | 15.2% | 18.7% | 23.7% | 20.9% |
| R&D Expenses | $2M | $6M | $5M | $3M | $0 |
| SG&A Expenses | $33M | $70M | $106M | $90M | $61M |
| Operating Expenses | $35M | $76M | $110M | $93M | $63M |
| Operating Income | -$24M | -$54M | -$68M | -$34M | -$22M |
| Operating Margin | -47.7% | -36.6% | -30.3% | -13.6% | -11.3% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$44M | -$28M | -$58M | -$28M | -$20M |
| Tax Expense | -$4M | -$772K | -$1M | -$255K | -$61M |
| Net Income | -$40M | -$27M | -$56M | -$27M | $41M |
| Net Margin | -79.3% | -18.7% | -24.9% | -11.0% | 21.0% |
| EPS (Diluted) | $-0.57 | $-0.38 | $-0.76 | $-0.35 | $0.50 |
| EBITDA | -$23M | -$70M | -$61M | -$28M | -$12M |
| Shares Outstanding | 70M | 71M | 74M | 77M | 82M |